Catalyst Pharma
CPRX31.4900.00% ( 0.000 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Catalyst Pharma(CPRX) the Revenue is 149.39 M (+5.63%);the EBIT is 73.23 M (+15.57%);the EPS is 0.5 (+11.11%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.15B5.63%
----
----
EBIT
0.07B15.57%
----
----
EPS
0.511.11%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf